Detection of Cardiotoxic Hazards

  • G. Zbinden
Conference paper
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 9)

Abstract

For the detection and quantitative assessment of cardiovascular toxicity, the morphological and biochemical studies used in routine toxicity tests must be supplemented with functional and metabolic measurements. Examples are given which show that the cardiotoxic effects of allylamine and emetine can be detected early by blood pressure and ECG monitoring. The same techniques are helpful in assessing potential drug interactions. For the hypoglycemic agent MTG measurement of mitochondrial function proved to be the most adequate method to demonstrate cardiotoxic hazard.

Key words

Cardiotoxicity Allylamine Emetine Amitriptyline 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson HH, Leake CD (1930) The oral toxicity of emetine hydrochloride and certain related compounds in rabbits and cats. Am J Trop Med 10: 249–259Google Scholar
  2. Bachmann E, Weber E, Zbinden G (1984) The effect of methyl-2-tetradecylglycidate (McNeil 3716) on heart mitochondrial metabolism in rats. Biochem Pharmacol 33: 1947–1950PubMedCrossRefGoogle Scholar
  3. Back CK, van Stee EW (1979) Various techniques for evaluating cardiodynamic function using chronically instrumented dogs. Pharm Ther 5: 103–113CrossRefGoogle Scholar
  4. Balazs T, Ferrans VJ, Ehrreich SJ, Johnson Gl, Herman EH, Atkinson JC, West WL (1981) Study of the mechanism of hydralazine-induced myocardial necrosis in the rat. Toxicol Appl Pharmacol 59: 524–534PubMedCrossRefGoogle Scholar
  5. Boor PJ, Moslen MT, Reynolds ES (1979) Allylamine cardiotoxicity: I. Sequence of pathologic events. Toxicol Appl Pharmacol 50: 581–592Google Scholar
  6. Elsner J, Knutti R (1981) The graphical representation of the time evolution of ECG data using a computer data storage and plot package. In: Budden R, Detweiler D, Zbinden G (eds) The rat ECG in pharmacology and toxicology. Pergamon Press, Oxford, p 161Google Scholar
  7. Grauwiler J (1965) Herz and Kreislauf der Säugetiere. Birkhäuser Verlag, Basel and Stuttgart Nymark M, Rasmussen J (1966) Effect of certain drugs upon amitriptylin induced electrocardiographic changes. Acta Pharmacol Toxicol 24: 148–156Google Scholar
  8. Opie LA (1980) Metabolic and drug-induced injury to the myocardium. In: Bristow MR (ed) Drug-induced heart disease. Elsevier/North Holland Biomedical Press, Amsterdam, p 81Google Scholar
  9. Ortmann R, Schaub M, Feiner A, Lauber J, Christen P, Walmeier PC (1984) Phenethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors. Psychopharmacology 84: 22–27PubMedCrossRefGoogle Scholar
  10. Pfannhauser W, Pechanek U (1984) Biogene Amine in Lebensmitteln: Bildung, Vorkommen, Analytik and toxikologische Bewertung. Z Ges Hyg 30: 66–76Google Scholar
  11. Tutwiler GF, Mohrbacher R, Ho W (1979) Methyl 2-tetradecylglycidate — an orally effective hypoglycemic agent which selectively inhibits long chain fatty acid oxidation. Diabetes 28: 242–248PubMedGoogle Scholar
  12. Zbinden G (1981) Assessment of cardiotoxic effects in subacute and chronic rat toxicity studies. In: Balazs T (ed) Cardiac toxicity, vol 3, CRC Press Inc, Boca Raton FL, p 7Google Scholar
  13. Zbinden G (1982) Current trends in safety testing and toxicological research. Naturwiss 69: 255–259PubMedCrossRefGoogle Scholar
  14. Zbinden G, Spichiger H (1982) Subchronic toxicity study of quinidine and maprotiline alone, and in combination in rats. Arch Toxicol 51: 43–51CrossRefGoogle Scholar
  15. Zbinden G, Brindle E, Pfister M (1977) Modification of adriamycin toxicity in rats fed a high fat diet. Agents Action 7: 163–170CrossRefGoogle Scholar
  16. Zbinden G, Kleinert R, Rageth B (1980) Assessment of emetime cardiotoxicity in a subacute toxicity experiment in rats. J Cardiovasc Pharmacol 2: 155–164PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • G. Zbinden
    • 1
  1. 1.Institute of ToxicologyETH and University of ZurichCH-SchwerzenbachSwitzerland

Personalised recommendations